This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
CNS Drugs Open Access 12 February 2020
-
Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients
npj Schizophrenia Open Access 06 April 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mothet JP, Parent AT, Wolosker H, Brady RO, Linden DJ, Ferris CD et al. Proc Natl Acad Sci USA 2000; 97: 4926–4931.
Tsai GC, Coyle JT . Annu Rev Pharmacol Toxicol 2002; 42: 165–179.
Chumakov I, Blumenfeld M, Guerrasimenko O, Cavarec L, Palicio M, Abderrahim H et al. Proc Natl Acad Sci USA 2002; 99: 13675–13680.
Boks MPM, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS . Eur Neuropsychopharmacol 2007; 17: 567–572.
Kapoor R, Lim KS, Cheng A, Garrick T, Kapoor V . Brain Res 2006; 1106: 205–210.
Verrall L, Walker M, Rawlings N, Benzel I, Kew JNC, Harrison PJ et al. Eur J Neurosci 2007; 26: 1657–1669.
Javitt D . Biol Psychiatry 2008; 63: 6–8.
Adage T, Trillat A-C, Quattropani A, Perrin D, Cavarec L, Shaw J et al. Eur Neuropsychopharmacol 2008; 18: 200–214.
Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H et al. Schizophr Res 2007; 90: 41–51.
Burnet PJW, Hutchinson L, von Hesling M, Gilbert E-J, Brandon NJ, Rutter AR et al. Schizophr Res 2008; doi 10.1016/j.schres.2008.02.009.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Burnet, P., Eastwood, S., Bristow, G. et al. D-Amino acid oxidase activity and expression are increased in schizophrenia. Mol Psychiatry 13, 658–660 (2008). https://doi.org/10.1038/mp.2008.47
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2008.47
This article is cited by
-
Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research
CNS Drugs (2022)
-
Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates
CNS Drugs (2020)
-
A systematic meta-analysis of the association of Neuregulin 1 (NRG1), d-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia
Journal of Neural Transmission (2018)
-
Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of d-amino acid oxidase inhibitors
Journal of Computer-Aided Molecular Design (2018)
-
Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients
npj Schizophrenia (2017)